News
- US University conducts an extended follow-Up study of the HPV Vaccine Delayed Booster Trial
- Update on rolling review of AstraZeneca’s COVID-19 vaccine
- FDA Approves First Generic of Drug Used to Treat Severe Hypoglycemia
- USDA and HHS Just Released the Dietary Guidelines for Americans, 2020-2025
- KU Leuven started a clinical trial for patients with The Neurocircuitry of Relief During Avoidance Learning in Patients With Obsessive-compulsive Disorder
- UK Pharmaceutical Company started a Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors
- Spanish University is about to start a clinical trial of Effect of Dry Needling on Surface Electromyographic Activity in Latent Trigger Points
- DC to Require Negative COVID-19 Test for Air Travelers from the United Kingdom to the U.S.
- Italian Foundation is undertaking a Rehabilitation With HHFNC in COPD in Nocturnal NIV
- Poland Cancer Centre begins clinical trial of HPV Serum Level and FDG PET CT in Patients With Cervical Cancer Treated With Radical Radiochemotherapy
- US company started a clinical trial of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- Pharmaceutical company conducts a clinical study to assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19
- US company evaluates Liver Fibrosis and Steatosis Versus MRE and MRI PDFF
- FDA Takes Further Steps to Confront Opioid Crisis Through Risk Evaluation and Mitigation Strategy Programs
- University School of Medicine started a clinical trial of Cardiac Markers in Depressed Patients With Coronary Heart Disease
- FDA authorizes marketing of new device designed to remove dead pancreatic tissue
- Clinical research center conducts clinical trial of Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies
- Canadian University carries out resistance training for men living with Obesity
- US company started clinicl trial of Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors
- WHO supports European countries’ response to new virus variant
- Health Canada authorizes Moderna COVID-19 vaccine
- Government of Canada provides $70 million in additional funding to the Red Cross for ongoing COVID-19 response
- Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
- HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
- Results of NIH-sponsored ACTIV-3 trial published
Clinical Research News
Предстоящие клинические испытания
-
Magnus MedicalCongressionally Directed Medical Research ProgramsРекрутинг
-
Nicholas ButowskiSiren BiotechnologyЕще не набираютГлиома | Новообразование головного мозга | Рецидивирующие глиомы высокой степени злокачественностиСоединенные Штаты
-
State University of New York at BuffaloЕще не набираютВовлечение пациентовСоединенные Штаты
-
Poitiers University HospitalЕще не набирают
-
Assistance Publique - Hôpitaux de ParisЕще не набираютСерповидно-клеточная анемия | Вазоокклюзионный кризис
-
University of California, IrvineРекрутингРак мозга | Рак ЦНС | Рак нервной системы | Метастатический рак головного мозгаСоединенные Штаты
-
Qualia Life SciencesРекрутинг
-
Guangdong Raynovent Biotech Co., LtdЕще не набираютФундаментальная наука
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationРекрутингВзрослые люди | Цифровая помощь для слабовидящих | Нарушения зренияГонконг
-
Shanghai General Hospital, Shanghai Jiao Tong University...Еще не набираютАденокарцинома протоков поджелудочной железы (PDAC)
-
Sun Yat-sen UniversityЕще не набираютОтказ от курения | ИИ-агент | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityЕще не набирают
